(Q44997764)

8 December 2017

title

Alfuzosin-induced acute hepatitis in a patient with chronic liver disease (English)

1 reference

8 December 2017

main subject

chronic liver disease

0 references

author name string

Omer Faruk Yolcu

1

1 reference

8 December 2017

Seyfettin Köklü

2

1 reference

8 December 2017

Aydin S Köksal

3

1 reference

8 December 2017

Osman Yüksel

4

1 reference

8 December 2017

Yavuz Beyazit

5

1 reference

8 December 2017

Omer Basar

6

1 reference

8 December 2017

language of work or name

English

0 references

publication date

27 July 2004

1 reference

Annals of Pharmacotherapy

8 December 2017

published in

1 reference

8 December 2017

volume

38

1 reference

8 December 2017

issue

9

1 reference

8 December 2017

page(s)

1443-1445

1 reference

Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia

8 December 2017

cites work

1 reference

The use of alpha-adrenoceptor antagonists in lower urinary tract disease.

21 January 2018

1 reference

Long-term treatment of benign prostatic hyperplasia with alfuzosin: a 24-30 month survey. BPHALF Group

21 January 2018

1 reference

Alfuzosin: a clinically uroselective alpha1-blocker

21 January 2018

1 reference

Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D633

1 reference

8 December 2017

1 reference